Physician profile
Amy E Mckee
NPI 1124352075
$4,262.70
in general payments reported to CMS, 2019-2025
12 companies · $345 in 2025
The $345 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $487 · 2022: $770 · 2023: $2,166 · 2024: $496 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,610 · Food and Beverage: $1,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,609.95 |
| Food and Beverage | $1,395.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $2,210.04 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $557.73 | 2023-2024 | Xarelto, Spravato |
| Novo Nordisk INC | $353.70 | 2021-2024 | Wegovy |
| Boston Scientific Corporation | $211.77 | 2025 | Ams 700 |
| Astrazeneca Pharmaceuticals Lp | $207.61 | 2021-2022 | |
| Abbott Laboratories | $165.77 | 2023 | Freestyle Libre 3 |
| Inspire Medical Systems, INC. | $134.93 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $132.77 | 2025 | |
| Aesculap Implant Systems, LLC | $105.00 | 2021 | |
| Alnylam Pharmaceuticals INC. | $95.96 | 2023 | Givlaari |
| Innovation Technologies INC | $69.42 | 2022 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Mckee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.